Skip to main content
Teva Pharmaceutical Industries Limited (TLV:TEVA)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
10,280
+914 (9.76%)
Apr 29, 2026, 5:29 PM IDT

TLV:TEVA Revenue

In the year 2025, Teva Pharmaceutical Industries had annual revenue of $17.26B USD with 4.32% growth. Teva Pharmaceutical Industries had revenue of $4.71B in the quarter ending December 31, 2025, with 11.40% growth.

Revenue
$17.26B
Revenue Growth
+4.32%
P/S Ratio
1.98
Revenue / Employee
$525.49K
Employees
32,842
Market Cap
108.92B ILS

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202517.26B714.00M4.32%
Dec 31, 202416.54B698.00M4.40%
Dec 31, 202315.85B921.00M6.17%
Dec 31, 202214.93B-953.00M-6.00%
Dec 31, 202115.88B-781.00M-4.69%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Danel (Adir Yeoshua) 2.90B
Amal Holdings A.D. 2.18B
BrainsWay 166.49M
SofWave Medical 279.39M
Kamada 575.31M
Bait Bakfar 109.62M
Ilex Medical 930.83M
Novolog (Pharm-Up 1966) 1.81B
Revenue Rankings

Teva Pharmaceutical Industries News

More News